2026-06-05

Added · Updated

Financial Supervisory Commission Securities and Futures Bureau Daily News (June 5, 2026)

An Cheng Biotechnology Co., Ltd. (OTC-listed, Stock Code 6610) completed the correction of its incomplete filing for a cash capital increase of 18,000,000 new shares with a total amount of NT$180,000,000 on June 3, 2026. Consequently, the seven-business-day review period for the effectiveness of this filing restarts from the date of correction, with effectiveness expected on June 8, 2026, assuming no major anomalies. No securities investment trust fund cases were approved, effective, or stopped on June 5, 2026.

Financial Supervisory Commission Taiwan logo

Taiwan

Financial Supervisory Commission Taiwan

Scan of the document's first page
Share

FSC published 12 documents in the last 30 days — get each new one by email the day it lands.

Read the rest free

Source: Financial Supervisory Commission Taiwan — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

More like this from FSC

FSC published 12 documents in the last 30 days. We email you each new one the day it's published.